ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,251.03
0.07%
Dow Jones
42,635.20
0.25%
Gold vs US Dollar
2,659.86
-0.10%
Brent Oil
75.635
-0.47%
Bitcoin
93,966.08
-1.13%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Aoxing Pharmaceutical Company New (delisted) (AXN)

  7. Aoxing Pharmaceutical Company New (delisted) (AXN) News

Aoxing Pharmaceutical Company New (delisted) (AXN)

Aoxing Pharmaceutical Company New (delisted)
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:AXN
DateTimeSourceHeadlineSymbolCompany
17/10/201717:28Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
06/10/201720:17Edgar (US Regulatory)(25)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
06/10/201710:03Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
29/09/201710:04Edgar (US Regulatory)Withdrawal of Registration Statement (ammendment) (aw)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
28/09/201710:04Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
27/09/201719:10Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
26/09/201715:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
25/09/201710:02Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
04/08/201720:31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
22/06/201720:37Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
15/05/201712:39Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
11/05/201714:21Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
11/05/201714:20Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
17/02/201717:34Edgar (US Regulatory)Amended Quarterly Report (10-q/a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
14/02/201722:41Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
14/11/201622:07Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
05/10/201620:33Edgar (US Regulatory)Annual Report (10-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
28/09/201620:17Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
23/06/201611:56Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
16/05/201611:06Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
03/05/201610:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
03/05/201610:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
08/02/201613:30PR Newswire (US)Aoxing Pharmaceuticals Q2 Revenue Up 27%; Net Income $2.1 Million, Up 265%AMEX:AXNAoxing Pharmaceutical Company New (delisted)
08/02/201613:18Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
01/02/201613:30PR Newswire (US)Aoxing Pharma Appoints Dr. James Chen as Chief Financial OfficerAMEX:AXNAoxing Pharmaceutical Company New (delisted)
01/02/201611:05Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
11/01/201621:35Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
10/12/201513:30PR Newswire (US)Aoxing Pharma Selected to Supply Zhongtongan to the Insurance System for the City of ShanghaiAMEX:AXNAoxing Pharmaceutical Company New (delisted)
04/12/201513:30PR Newswire (US)Aoxing Pharma Announces Opening Of Government Funded Drug Research CenterAMEX:AXNAoxing Pharmaceutical Company New (delisted)
04/12/201513:00PR Newswire (US)Aoxing Pharma Announces Resignation of CFOAMEX:AXNAoxing Pharmaceutical Company New (delisted)
 Showing the most relevant articles for your search:AMEX:AXN

Your Recent History

LSE
KIE
Kier
LSE
BIRD
Blackbird
LSE
DEMG
Deltex Medical
LSE
DGI9
Digital 9 Infrastructure
LSE
GFM
Griffin Mining
LSE
PIER
Brighton Pier
LSE
MNG
M&g
LSE
RBGP
Rbg
LSE
YU.
Yu
LSE
KIST
Kistos
LSE
SGRO
Segro
LSE
GRG
Greggs
LSE
IMI
Imi
LSE
SQZ
Serica Energy
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads